English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe Autoimmune Association announces the appointment of Eline (Nina) T. Luning Prak, MD, PhD, as chair of the organization’s Medical and Scientific Advisory Council.
Tag: Autoimmune
New $17 million grant establishes LJI as global hub for immunology data curation and analysis
A new grant of over $17 million from the National Institute of Allergy and Infectious Diseases (NIAID) has established La Jolla Institute for Immunology (LJI) as the leading institute for human immunology data curation, analysis, and dissemination. With this funding, LJI has taken the helm of the Human Immunology Project Consortium Data Coordinating Center, a critical tool in the effort to fuel scientific collaboration in immunoprofiling and highlight findings from the overall Human Immunology Project Consortium (HIPC).
SOCIAL MEDIA INFLUENCER GIGI ROBINSON TO DELIVER KEYNOTE AT THE AUTOIMMUNE COMMUNITY SUMMIT
Gigi Robinson will deliver a lunch keynote session at the Autoimmune Association’s annual Autoimmune Community Summit.
What is autoimmune-associated epilepsy: Dr. Claude Steriade
What is autoimmune-associated epilepsy, and how is it different from acute seizures with an autoimmune cause? How can clinicians best diagnose and treat these conditions? Sharp Waves reporter Dr. Maryam Nabavi-Nouri spoke with Dr. Claude Steriade.
Boot Camp for the Immune System
Researchers identify new mechanism that teaches immune cells-in-training to spare the body’s own tissues while attacking pathogens.
AUTOIMMUNE ASSOCIATION SUPPORTS RECOMMENDATIONS OF REPORT TO ADVANCE RESEARCH FOR AUTOIMMUNE DISEASE
The Autoimmune Association supports a recommendation that the National Institutes of Health (NIH) should create an Office of Autoimmune Disease/Autoimmunity Research within the Office of the Director, a key finding from a new report from the National Academies of Sciences, Engineering, and Medicine.
AUTOIMMUNE ASSOCIATION ANNOUNCES 2022 COMMUNITY SUMMIT
The Autoimmune Association, the world’s leading nonprofit organization dedicated to autoimmune awareness, advocacy, education, and research, will convene its second annual Autoimmune Community Summit on Friday, October 21 and Saturday, October 22, 2022.
Researchers Identify Potential Target for Treating Autoimmune Diseases
New research using a mouse model for multiple sclerosis has uncovered a potential new area to explore for possible treatments for autoimmune disorders.
Study Finds Systemic Autoimmune Disease Patients Fare Well After Transplants, Making Surgery a Viable Treatment Option for End-Stage Lung Disease
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without any systemic causes of end-stage lung disease.
American Autoimmune Related Diseases Association Becomes the Autoimmune Association
To mark its 30-year legacy and global impact on the autoimmune community, today, the American Autoimmune Related Diseases Association (AARDA) is pleased to announce its new name: the Autoimmune Association.
American Autoimmune Related Diseases Association Appoints Molly Murray President and CEO
The American Autoimmune Related Diseases Association (AARDA), the world’s leading nonprofit organization dedicated to autoimmune awareness, advocacy, education, and research, appointed Molly Murray, CAE as President and CEO. Murray will lead AARDA’s efforts to bring a national focus to autoimmunity, the major cause of over 100 serious chronic diseases.
Top Researchers Identify Areas for Autoimmune Disease Research at AARDA-Hosted Colloquium
The American Autoimmune Related Disease Association (AARDA) hosted the 15th Noel Rose Scientific Colloquium on May 1, 2021, bringing together high-level researchers from different areas and specialties.
Patient support programs for painful conditions may reduce opioid use
Programs that provide ongoing support to patients with painful conditions and complex medication regimens may also help them avoid using potentially risky opioid pain medications, or reduce the amount they use, a new study finds.
Research Group Identifies Potential Therapeutic Target for Lupus
Inhibiting IRE1α, a molecule activated by the endoplasmic reticulum in neutrophils, counters disease progression in lupus mice.
Cancer Immunotherapy May Also Treat Certain Autoimmune Diseases
The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.
Study Reveals Details of Immune Defense Guidance System
At the beginning of an immune response, a molecule known to mobilize immune cells into the bloodstream, where they home in on infection sites, rapidly shifts position, a new study shows. Researchers say this indirectly amplifies the attack on foreign microbes or the body’s own tissues.
Expert Alert: Encephalitis prevention another reason to receive COVID-19 vaccine
Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of the brain.
“Encephalitis cases have been reported in patients with COVID-19, although on the whole it appears to be a relatively rare complication,” says Michel Toledano, M.D., a Mayo Clinic neurologist.
In the case of encephalitis caused by communicable diseases for which there is a vaccine available, getting vaccinated is the best way of preventing the disease.
STUDY PINS DOWN NUMBER OF AMERICANS WITH MOST COMMON FORM OF LUPUS
Just over 200,000 Americans suffer from systemic lupus erythematosus, or SLE, a condition in which the body’s immune system mistakenly attacks its own healthy tissues, especially joints and skin, a new study shows.
National Research Effort Discovers Relationship Between Inflammation, Metabolism and Scleroderma Scarring
Study finds NAD+ break down leads to multi organ scarring, providing now a previously undiscovered pathogenic role of the enzyme CD38 in disease scarring.
AARDA Announces Leadership Transition
The American Autoimmune Related Diseases Association announced that Randall Rutta, President and CEO, is leaving to join the National Health Council (NHC) as its CEO, effective February 12, 2021.
Protein Linked to Progressive Lung Scarring in Scleroderma Patients
Osteopontin is discovered as the culprit behind these patients’ main cause of death. However, a repurposed immunosuppressive drug may combat the pro-inflammatory protein.
Study explores sleep apnea, autoimmune disease link
New research by University of Georgia scientists sheds light on why people with obstructive sleep apnea may have associated autoimmune disorders. The results could lead to better approaches to treatment and possibly new drug therapies.
Physicians issue warning about rare neurological condition, expected to appear this fall
Pediatricians Henry David, MD, and Madan Kumar, DO, of the University of Chicago Medicine Comer Children’s Hospital warn parents of young children to watch out for symptoms of acute flaccid myelitis (AFM), a rare neurological disorder linked to viral infections that can lead to permanent paralysis.
American College of Rheumatology Secures $7M Grant to Address Gaps in Lupus Care and Treatment
The American College of Rheumatology (ACR) was recently awarded a $7M grant to reduce inequities in symptom recognition, care and disease management of systemic lupus erythematosus (lupus). The grant, which will be led by the ACR’s Collaborative Initiatives (COIN) department, begins on Sept. 30.
Children Who Take Prescription Steroids at Increased Risk for Diabetes, High Blood Pressure, Blood Clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.
Pregnant mother’s immunity tied to behavioral, emotional challenges for kids with autism
Children with autism born to mothers who had immune conditions during their pregnancy are more likely to have behavioral and emotional problems, a UC Davis Health study has found. Offspring sex may also interact with maternal immune conditions to influence outcomes, particularly in terms of a child’s cognition.
AARDA MOURNS THE LOSS OF DR. NOEL R. ROSE, “THE FATHER OF AUTOIMMUNITY”
AARDA Tribute to Dr. Noel R. Rose, “The Father of Autoimmunity”
Study: Enzyme Could Prove Effective in Treating Tumors and Inflammatory Diseases in Lung
Findings from a research study, led by scientists at Henry Ford, suggest an enzyme could play an important role in the treatment of cancer and autoimmune diseases in the airway.
Dual role discovered for molecule involved in autoimmune eye disease
The inflammatory molecule interleukin-17A (IL-17A) triggers immune cells that in turn reduce IL-17A’s pro-inflammatory activity, according to a study by National Eye Institute (NEI) researchers.
DNA Misfolding in White Blood Cells Increases Risk for Type 1 Diabetes
Researchers found, in mice, that changes in DNA sequence can trigger the chromosomes to misfold in a way that puts one at a heightened risk for Type 1 diabetes. The study revealed that differences in DNA sequences dramatically changed how the DNA was folded inside the nucleus, ultimately affecting the regulation of genes linked to the development Type 1 diabetes.
AARDA Partners with AutoimmuneMom
Detroit, MI (January 30, 2019) – The American Autoimmune Related Disease Association (AARDA) is thrilled to announce our new partnership with AutoimmuneMom. For the last seven+ years, AutoimmuneMom has created a digital community through the hard work and dedication of Katie Cleary. Now, AARDA will proudly host the content that has brought together people with autoimmune disease through stories of how autoimmune disease impacts motherhood and pregnancy, general autoimmune information, personal stories, and doctor recommendations. AutoimmuneMom will continue to maintain its social media presence, but all website content will be hosted on AARDA.org.
Cedars-Sinai Receives $20M to Create Kao Autoimmunity Institute
Cedars-Sinai today announced a $20 million gift from Dr. and Mrs. Min H. Kao and the Kao Family Foundation to create the Kao Autoimmunity Institute to advance research and treatment of rheumatologic diseases. The gift also will establish the Scleroderma Program within the institute to provide interdisciplinary and integrated care for scleroderma patients and to support research, outreach, training and education to help those with the disease.
Penn Researchers Uncover Dose of Medication More Likely to Put Patients with a Rare Autoimmune Disease into Complete Remission
Researchers from Penn compare a lymphoma-dose regimen of rituximab to a rheumatoid arthritis regimen for the treatment of pemphigus.
Study: First Evidence of Immune Response Targeting Brain Cells in Autism
In a paper published in Annals of Neurology, a physician-scientist at Beth Israel Deaconess Medical Center (BIDMC), and colleagues report the presence of cellular features consistent with an immune response targeting specialized brain cells in more than two thirds of autistic brains analyzed postmortem. These cellular characteristics – not previously observed in autism – lend critical new insight into autism’s origins and could pave the way to improved diagnosis and treatment for people with this disorder.
AUTOIMMUNE ASSOCIATION HOSTS TWO SIGNATURE EVENTS IN PITTSBURGH:
The American Autoimmune Related Diseases Association (AARDA) partners with AHN Autoimmunity Institute to present a free public forum on autoimmune disease and the inaugural Pittsburgh Autoimmune Walk.